These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2009763)

  • 21. [Use of effort tests for evaluation of the effectiveness of digitalis treatment in atrial fibrillation. Correlation with blood levels of digoxin].
    Gavrilescu S; Cristodorescu R; Deutsch G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):325-38. PubMed ID: 6113645
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of digoxin on the ventricular rate variability during paroxysmal atrial fibrillation.
    Hnatkova K; Murgatroyd FD; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1968-71. PubMed ID: 8945079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.
    Beasley R; Smith DA; McHaffie DJ
    Br Med J (Clin Res Ed); 1985 Jan; 290(6461):9-11. PubMed ID: 3917348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
    Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
    Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma digoxin concentrations in patients with atrial fibrillation and indications for the association with other antiarrhythmic agents.
    Cargnelli G; Domeneghetti F; Ferrari M; Malacini P; Roberti G
    Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):384-8. PubMed ID: 892956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of digitalis glycosides in atrial fibrillation].
    Knez A; Haberl R; Steinbeck G
    Z Kardiol; 1994; 83 Suppl 5():71-3. PubMed ID: 7846948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.
    Boriani G; Biffi M; Diemberger I; Martignani C; Branzi A
    Drugs; 2003; 63(14):1489-509. PubMed ID: 12834366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of serum digoxin concentration measurement in the control of digoxin therapy in atrial fibrillation.
    Halkin H; Kleiner A; Saginer A; Almog S; Millman P; Tirosh M
    Isr J Med Sci; 1979 Jun; 15(6):490-3. PubMed ID: 457382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise.
    Steinberg JS; Katz RJ; Bren GB; Buff LA; Varghese PJ
    J Am Coll Cardiol; 1987 Feb; 9(2):405-11. PubMed ID: 3805530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The plasma digoxin concentration, red cell rubidium 86 uptake and control of ventricular rate in patients being digitalized for artrial fibrilation.
    Hibble AG; Grahame-Smith DG
    Clin Sci; 1972 Jan; 42(1):3P. PubMed ID: 5008538
    [No Abstract]   [Full Text] [Related]  

  • 32. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
    Davy JM; Herold M; Hoglund C; Timmermans A; Alings A; Radzik D; Van Kempen L;
    Am Heart J; 2008 Sep; 156(3):527.e1-9. PubMed ID: 18760136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of digitalis: a prospective study on the posology of digoxin with weekly interruption].
    Soto Pedre E; Castro Beirás A; Cuña Estévez B
    Rev Esp Cardiol; 1990; 43(7):438-43. PubMed ID: 2093956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation.
    Lang R; Klein HO; Weiss E; David D; Sareli P; Levy A; Guerrero J; Di Segni E; Kaplinsky E
    Chest; 1983 Mar; 83(3):491-9. PubMed ID: 6337787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma digoxin levels and the interbeat interval signal in atrial fibrillation.
    Penchas S; Zajicek G
    Z Kardiol; 1978 Feb; 67(2):104-8. PubMed ID: 636516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation.
    Bøtker HE; Toft P; Klitgaard NA; Simonsen EE
    Br Heart J; 1991 Jun; 65(6):337-41. PubMed ID: 2054244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation.
    Lleva P; Aronow WS; Gutwein AH
    Am J Ther; 2009; 16(6):e41-3. PubMed ID: 19940604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation.
    Matsuda M; Matsuda Y; Yamagishi T; Takahashi T; Haraguchi M; Tada T; Kusukawa R
    Cardiovasc Res; 1991 Jun; 25(6):453-7. PubMed ID: 1889058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Should chronic atrial fibrillation be treated with digoxin?].
    Garre K
    Ugeskr Laeger; 1990 Aug; 152(35):2475-8. PubMed ID: 1976285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.